Caricamento...
LANTERN: a randomized study of QVA149 versus salmeterol/fluticasone combination in patients with COPD
BACKGROUND: The current Global initiative for chronic Obstructive Lung Disease (GOLD) treatment strategy recommends the use of one or more bronchodilators according to the patient’s airflow limitation, their history of exacerbations, and symptoms. The LANTERN study evaluated the effect of the long-a...
Salvato in:
| Pubblicato in: | Int J Chron Obstruct Pulmon Dis |
|---|---|
| Autori principali: | , , , , , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Dove Medical Press
2015
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4461092/ https://ncbi.nlm.nih.gov/pubmed/26082625 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/COPD.S84436 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|